Tyglar SRL
Dissolution volontaire – liquidationTyglar reported total assets of 40,846 € at the end of the 2025 financial year (annual accounts filed with the NBB on 24 Nov 2025).
The score of Tyglar shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets -78 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Tyglar's annual accounts
Filed annual accounts
- Year ended 27 Mar 2025filed on 24 Nov 2025
- Year ended 27 Mar 2024filed on 30 Oct 2024
- Year ended 31 Dec 2023filed on 31 Aug 2024
- Year ended 31 Dec 2022filed on 15 Jul 2023
- Year ended 31 Dec 2021filed on 27 Jul 2022
Tyglar's financial analysis
- Solvency96.7%sector median: 60.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Tyglar
Tyglar's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0721.506.190
- VAT number
- BE0721506190
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SRL
- Incorporated
- 25 Feb 2019
- Registered office
- 2811 Mechelen
- Latest accounts
- 2025 · filed on 24 Nov 2025
- Activity
- Research and experimental development on biotechnology (NACE 72101)
Tyglar (SRL) has been based in Mechelen since 2019, active in: research and experimental development on biotechnology. For 2025, it reports a net profit of 5,303 € and equity of 39,490 €; its revenue is not published. Its solvency stands at 96.7%, above the median of its sector (60.4%).
Companies similar to Tyglar
Companies in the same business, of comparable size and area, outside its group.
- Grand Medical (Europe) Research and experimental development on natural sciences and engineering Niel · balance sheet 135,260 €
- 4K Services Belgium Research and experimental development on natural sciences and engineering Etterbeek · balance sheet 59,971 €
- RheADC Manufacture of basic pharmaceutical products Leuven · balance sheet 31,395 €
- Nanogyre Research and experimental development on natural sciences and engineering Liège · balance sheet 22,232 €
- P & X Medical Research and experimental development on natural sciences and engineering Wevelgem · balance sheet 50,706 €
- Base LT Research and experimental development on natural sciences and engineering Herbeumont · balance sheet 47,144 €
- TYROScreen Research and experimental development on natural sciences and engineering Herve · balance sheet 48,550 €
- Zyntra Advisory Research and experimental development on natural sciences and engineering Etterbeek · balance sheet 22,045 €
Frequently asked questions about Tyglar
What is the revenue of Tyglar?
Tyglar files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Tyglar?
In Belgium, the VAT number is the company number prefixed with BE: BE0721506190 for Tyglar, if the company is VAT-registered. Its company number (CBE) is 0721.506.190.
Where is the registered office of Tyglar?
According to the CBE register, the registered office of Tyglar is in 2811 Mechelen.
What is the equity of Tyglar?
At the close of the 2025 financial year, the equity of Tyglar amounts to 39,490 €, a solvency of 96.7% of total assets.
Who manages Tyglar?
The register lists 1 active mandates at Tyglar. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Tyglar
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →